Significance of USP General Chapters above <999> for FDA
Recommendation
22/23 September 2020
Register now for ECA's GMP Newsletter
GMP News No. 832
|
GMP News 8 November 2006 |
|
Significance of USP General Chapters above <999> for FDA |
|
Only few users of the USP know that there is a difference between the General Chapters with numbers below <999> and those above <999>. The corresponding statement can be found in the USP's General Notices. The text says that a General Chapter with a number below <1000> is mandatory, whereas General Chapters with numbers above <1000> are considered interpretations and thus do not represent official standards and binding requirements. A question on this subject was submitted to the FDA. In a
Q&A forum on current GMP questions, the FDA answered
the questions whether USP General Chapters above <999> were equivalent to FDA guidances, which purpose these General Chapters have and how they should
be used by manufacturers of medicinal products. On 4 October, the FDA
published the answer in the Q&A forum. |
|
The pharmacopoeial requirements are one of the topics
of the education course Quality Control of Raw Materials in Vienna, Austria, on 30-31 January 2007. |
| Author: Dr Günter Brendelberger On behalf of ECA The answers by Richard Friedman and Jon Clark from
FDA's CDER can be found here: |
GMP Conferences by Topics
- Quality Assurance
- GMP in Biotechnology
- Microbiology
- Regulatory Affairs
- GMP in Pharmaceutical Development
- Quality Control
- GDP
- Sterile / Aseptic Manufacturing
- Computer Validation
- Validation
- Technical Operations
- GMP for APIs and Excipients
- Medical Devices
- GMP Basic Training Courses
- Packaging
- Data Integrity